Abstract:Ethnopharmacological relevance: Lung cancer is the leading cause of cancer incidence and mortality worldwide. Arenobufagin (Arg), a representative natural bufadienolide compound, is one of the major bioactive components isolated from toad venom ("Chan Su"named in Chinese to treat multifarious clinical neoplasms in China). However, the underlying molecular mechanisms that Arg inhibited the metastasis of lung cancer cells remain poorly understood. Materials and methods: The mobility capacities of lung cancer cells treated with Arg were evaluated using wound healing assay. The anti-migratory and anti-invasive effects of Arg on lung cancer cells were investigated by transwell invasion assay and matrigel invasion assay. iTRAQ-labeled LC-MS proteomics was used to analyze the potential proteins related to metastasis in lung cancer cells treated with Arg and differentially-expressed proteins related to EMT and NF kappa B signaling cascade were further confirmed by Western blotting assay. The changed subcellular localization of p65 in lung cancer A549 and H1299 cells treated with Arg was detected by immunofluorescence staining. Molecular docking and molecular dynamic (MD) simulation assay were performed to verify the binding between Arg and IKK alpha/IKK beta. siRNA knockdown was used to check whether Arg inhibited EMT of lung cancer cells via targeting NF kappa B signaling cascade, which was further verified by in vivo study of lung cancer cell xenograft mice model and pulmonary metastasis mice model accompanying with immunohistochemical and hematoxylin-eosin (HE) staining. Results: Arg suppressed the wound closure of lung cancer cells using wound healing assay. Moreover, Arg significantly inhibited the migration and invasion of lung cancer cells by transwell invasion assay and matrigel invasion assay. 24 unique differentially-expressed proteins related to metastasis in lung cancer cells treated with Arg were identified using iTRAQ-labeled LC-MS proteomics and 14 differentially-expressed proteins related to EMT were further confirmed by Western blotting assay. Arg significantly decreased the phosphorylation of IKK beta and p65 in the cytoplasm of lung cancer cells by Western blotting assay, and remarkably reduced the release of p65 from the cytoplasm to the nucleus. Arg could be bound in the ATP binding pocket of IKK alpha and IKK beta by molecular docking assay, and MD simulation assay further demonstrated that Arg binding to the ATPb-inding pocket of IKK beta was very stable in 300 ns MD simulation, compared with the binding of Arg and IKK alpha. IKK beta/NF kappa B signaling cascade was also involved in the inhibitory effect of Arg on EMT of lung cancer cells by siRNA knockdown assay. The study of lung cancer cell xenograft mice model and pulmonary metastasis mice model in vivo indicated that Arg inhibited EMT and suppressed migration and invasion of lung cancer cells via downregulating IKK beta/NF kappa B signaling cascade. Conclusion: In the present study, we explored the molecular mechanism of Arg prohibiting the metastasis of lung cancer cells in vitro and in vivo, which displayed Arg could target IKK beta to inactive NR kappa B signaling cascade and further change the expression of proteins related to EMT. These results highlight the potential of toad venom as a potential chemotherapeutic agent and warrant its development as the clinical therapy for lung cancer.

Arenobufagin, isolated from Bufo viridis toad venom, inhibits A549 cells proliferation by inducing apoptosis and G2/M cell cycle arrest

Abstract 1328: Arenobufagin Induces Apoptosis, Autophagy and Cell Cycle Arrest in Hepatocellular Carcinoma Cells

Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

Arenobufagin, a Bufadienolide Compound from Toad Venom, Inhibits VEGF-mediated Angiogenesis Through Suppression of VEGFR-2 Signaling Pathway

Arenobufagin, Isolated from Toad Venom, Inhibited Epithelial-to-mesenchymal Transition and Suppressed Migration and Invasion of Lung Cancer Cells Via Targeting IKKβ/NFκB Signal Cascade.

Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.

Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis

Anti-angiogenetic Effect of Arenobufagin in Vitro and in Vivo

Arenobufagin Promoted Oxidative Stress-Associated Mitochondrial Pathway Apoptosis in A549 Non-Small-Cell Lung Cancer Cell Line

Research progress in the anti-cancer activity and related mechanisms of arenobufagin

Arenobufagin Enhances the Radiosensitivity of Cervical Cancer Cells by Inhibiting the NF-?B Signaling Pathway

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

Arenobufagin enhances T-cell anti-tumor immunity in colorectal cancer by modulating HSP90β accessibility

Bufarenogin induces intrinsic apoptosis via Bax and ANT cooperation

Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.

Ginkgolide B Inhibits Lung Cancer Cells Promotion Via Beclin-1-dependent Autophagy

Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells

Isolation, Identification and Chemical Modification of Bufadienolides from Bufo melanostictus Schneider and Their Cytotoxic Activities against Prostate Cancer Cells

Pelargonidin inhibits cell growth and promotes oxidative stress‐mediated apoptosis in lung cancer A549 cells

Effusanin B Inhibits Lung Cancer by Prompting Apoptosis and Inhibiting Angiogenesis

Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis